Innovative Vaccine Technologies
Biotechnology Research • 
Salt Lake City, Utah, United States • 1-10 Employees
Company overview
| Headquarters | Salt Lake City, Utah, United States |
| Website | |
| NAICS | 541714 |
| Founded | 2020 |
| Employees | 1-10 |
Key Contact at Innovative Vaccine Technologies
Brent Taylor
Co-Founder/Owner
Innovative Vaccine Technologies Email Formats
Innovative Vaccine Technologies uses 1 email format. The most common is {first initial} (e.g., j@ivtglobal.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@ivtglobal.com | 100% |
About Innovative Vaccine Technologies
IVT along with Hexamer Therapeutics has developed a new generation of peptide vaccines with a versatile platform technology for infectious diseases and cancers. Innovative Vaccine Technologies is working with U.S. and global leaders in a dedicated effort to end the Covid-19 pandemic as well as assist in providing vaccines and therapeutics to combat certain cancers. Innovative Vaccine Technologies identifies and partners with industry leaders in peptide production to optimize vaccine manufacturing and distribution.
Innovative Vaccine Technologies revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Innovative Vaccine Technologies has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Innovative Vaccine Technologies has never raised funding before.
New Zealand
Spain
Czechia
Australia
Frequently asked questions
4.8
40,000 users
